Skip to main content
TipRanks
Go Ultimate75% OFF

Stephen Hill Insider Profile

11 Followers

Stephen Hill, Director at Lipocine, holds 12.75K shares in Lipocine (Ticker: LPCN), holds 18.00K shares in Cellectar Biosciences (Ticker: CLRB), holds 1.19K shares in Gyre Therapeutics (Ticker: GYRE).

Stephen Hill's Trading History

LPCN
Lipocine
Dec 17, 2020DirectorUninformative Buy10.35K$21.80K
CLRB
Cellectar Biosciences
Jun 08, 2020DirectorInformative Buy19.26K$20.52K
GYRE
Gyre Therapeutics
Sep 06, 2018DirectorUninformative Sell1.91K$5.13K
ARQL
Arqule
―――$0.00

You May Also Like

Stephen Hill insider profile FAQ

What is the percentage of profitable transactions made by Stephen Hill?
The percentage of profitable transactions made by Stephen Hill is 67%.
What is the average return per transaction made by Stephen Hill?
The average return per transaction made by Stephen Hill is 27.40%.
What stocks does Stephen Hill hold?
Stephen Hill holds: LPCN, GYRE, ARQL, CLRB stocks.
What was Stephen Hill’s latest transaction?
Stephen Hill’s latest transaction was an Uninformative Buy of $10.35K.
What was Stephen Hill's most profitable transaction?
Stephen Hill’s most profitable transaction was an Informative Buy of LPCN stock on November 13, 2014. The return on the trade was 166.00%.
What is Stephen Hill's role in Lipocine?
Stephen Hill's role in Lipocine is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.